We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. Galectin-3 and cancer immunotherapy: a glycobiological rationale to overcome tumor immune escape

    Immunotherapy with checkpoint inhibitors (ICIs) has radically changed the landscape of therapeutic opportunities in oncology, but much still needs to...

    Giorgia Scafetta, Calogero D’Alessandria, Armando Bartolazzi in Journal of Experimental & Clinical Cancer Research
    Article Open access 06 February 2024
  2. Hsa_circ_0136666 stimulates gastric cancer progression and tumor immune escape by regulating the miR-375/PRKDC Axis and PD-L1 phosphorylation

    Background

    Targeted drugs are not quite effective for prolonging the survival of patients with gastric cancer due to off-target effects as well as...

    Zhenyan Miao, Jifei Li, ... Yingying **ng in Molecular Cancer
    Article Open access 13 December 2023
  3. AMPKα2 promotes tumor immune escape by inducing CD8+ T-cell exhaustion and CD4+ Treg cell formation in liver hepatocellular carcinoma

    Background

    Adenosine monophosphate-activated protein kinase (AMPK) is associated with the development of liver hepatocellular carcinoma (LIHC)....

    Yan Ouyang, Yan Gu, ... Shichao Zhang in BMC Cancer
    Article Open access 01 March 2024
  4. Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments

    The malignant tumor is a multi-etiological, systemic and complex disease characterized by uncontrolled cell proliferation and distant metastasis....

    Zhennan Yuan, Yingpu Li, ... Min **ao in Molecular Cancer
    Article Open access 11 March 2023
  5. Tumor-associated macrophage-derived exosomes LINC01592 induce the immune escape of esophageal cancer by decreasing MHC-I surface expression

    Background

    TAMs (tumor-associated macrophages) infiltration promotes the progression of esophageal cancer (EC). However, the underlying mechanisms...

    **nwei Qiao, Zaixing Cheng, ... **song Li in Journal of Experimental & Clinical Cancer Research
    Article Open access 02 November 2023
  6. Immune Escape Mechanism of Cancer

    Purpose of Review

    Cancer immune evasion is still a major obstacle in elimination of cancer cells and current cancer treatment. This review focuses on...

    Article 11 December 2023
  7. Tumor Microenvironment and Immune Escape in the Time Course of Glioblastoma

    Glioblastoma multiforme (GBM) is the most aggressive primary brain tumor with a malignant prognosis. GBM is characterized by high cellular...

    Assunta Virtuoso, Ciro De Luca, ... Roberto Giovannoni in Molecular Neurobiology
    Article Open access 01 September 2022
  8. Invasive FoxM1 phosphorylated by PLK1 induces the polarization of tumor-associated macrophages to promote immune escape and metastasis, amplified by IFITM1

    Background

    Understanding the mechanism behind immune cell plasticity in cancer metastasis is crucial for identifying key regulators. Previously we...

    Rong Xu, Young-Joo Lee, ... Hyungshin Yim in Journal of Experimental & Clinical Cancer Research
    Article Open access 16 November 2023
  9. Genetic immune escape landscape in primary and metastatic cancer

    Studies have characterized the immune escape landscape across primary tumors. However, whether late-stage metastatic tumors present differences in...

    Francisco Martínez-Jiménez, Peter Priestley, ... Edwin Cuppen in Nature Genetics
    Article Open access 10 May 2023
  10. DNA hypermethylation driven by DNMT1 and DNMT3A favors tumor immune escape contributing to the aggressiveness of adrenocortical carcinoma

    Background

    Adrenocortical carcinoma is rare and aggressive endocrine cancer of the adrenal gland. Within adrenocortical carcinoma, a recently...

    Gwenneg Kerdivel, Floriane Amrouche, ... Valentina Boeva in Clinical Epigenetics
    Article Open access 02 August 2023
  11. Targeting RNA N6-methyladenosine modification: a precise weapon in overcoming tumor immune escape

    Immunotherapy, especially immune checkpoint inhibitors (ICIs), has revolutionized the treatment of many types of cancer, particularly advanced-stage...

    Wei Li, Yi Hao, ... Da Pang in Molecular Cancer
    Article Open access 07 September 2022
  12. Correlation of the tumor escape phenotype with loss of PRELP expression in melanoma

    Background

    Despite immunotherapies having revolutionized the treatment of advanced cutaneous melanoma, effective and durable responses were only...

    Helene Schäfer, Karthikeyan Subbarayan, ... Barbara Seliger in Journal of Translational Medicine
    Article Open access 20 September 2023
  13. Immunological Landscape of Head and Neck Cancer: Mechanisms of Immune Escape and the Tumor Microenvironment

    In order for transformed cells to form tumors, they must escape from the ongoing pressure of the immune system. Distinct changes within tumor cells...
    Nicole C. Schmitt, Brendan L. C. Kinney, Robert L. Ferris in Immunotherapy for Head and Neck Cancer
    Chapter 2022
  14. Immunosuppression, immune escape, and immunotherapy in pancreatic cancer: focused on the tumor microenvironment

    Pancreatic ductal adenocarcinoma (PDAC), the most common type of pancreatic cancer, is characterized by poor treatment response and low survival...

    Yu-Heng Zhu, Jia-Hao Zheng, ... Yan-Miao Huo in Cellular Oncology
    Article 11 November 2022
  15. Circular RNA circWWC3 augments breast cancer progression through promoting M2 macrophage polarization and tumor immune escape via regulating the expression and secretion of IL-4

    Interaction between tumor cells and tumor microenvironment (TME) is critical to promote tumor progression and metastasis. As the most abundant immune...

    Yang Zheng, Shuguang Ren, ... Meixiang Sang in Cancer Cell International
    Article Open access 22 August 2022
  16. The Role of Intra-Tumor Hypoxia in Cancer Cells Immune Escape Mechanism

    The tumor microenvironment (TME) is an intricate environment consisting of distinct cell types, aberrant vasculature, and immunosuppressive cytokines...
    Pooya Farhangnia, Ali-Akbar Delbandi, ... Mahzad Akbarpour in Handbook of Cancer and Immunology
    Living reference work entry 2022
  17. Acidosis-mediated increase in IFN-γ-induced PD-L1 expression on cancer cells as an immune escape mechanism in solid tumors

    Immune checkpoint inhibitors have revolutionized cancer therapy, yet the efficacy of these treatments is often limited by the heterogeneous and...

    Philipp Knopf, Dimitri Stowbur, ... Manfred Kneilling in Molecular Cancer
    Article Open access 15 December 2023
  18. Crosstalk between oxidative phosphorylation and immune escape in cancer: a new concept of therapeutic targets selection

    Background

    Cancer is increasingly recognized as a metabolic disease, with evidence suggesting that oxidative phosphorylation (OXPHOS) plays a...

    Xutong Qiu, Yi Li, Zhuoyuan Zhang in Cellular Oncology
    Article 11 April 2023
  19. KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape

    Trogocytosis is an active process that transfers surface material from targeted to effector cells. Using multiple in vivo tumor models and clinical...

    Ye Li, Rafet Basar, ... Katayoun Rezvani in Nature Medicine
    Article 29 September 2022
Did you find what you were looking for? Share feedback.